Axsome Therapeutics (AXSM) Goodwill (2022 - 2026)

Axsome Therapeutics' Goodwill history runs 5 years deep, the most recent figure standing at $12.0 million for Q1 2026.

• In Q1 2026, Goodwill changed 0.35% year-over-year to $12.0 million; the TTM figure through Mar 2026 stood at $12.0 million (changed 0.35% YoY), while the FY2025 annual figure was $12.0 million, changed 0.35% from the prior year.
• Goodwill came in at $12.0 million for Q1 2026 at Axsome Therapeutics, roughly flat from $12.0 million in the prior quarter.
• In the past five years, Goodwill ranged from a high of $12.0 million in Q2 2023 to a low of $10.3 million in Q4 2022.
• A 5-year average of $11.8 million and a median of $12.0 million in 2023 frame the typical range for Goodwill.
• Across the five-year window, Goodwill increased 16.39% in 2023 and retreated 0.35% in 2024, its largest moves.
• Axsome Therapeutics' Goodwill stood at $10.3 million in 2022, then climbed by 16.39% to $12.0 million in 2023, then changed by 0.0% to $12.0 million in 2024, then grew by 0.35% to $12.0 million in 2025, then changed by 0.0% to $12.0 million in 2026.
• According to Business Quant data, Goodwill over the past three periods registered $12.0 million, $12.0 million, and $12.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison